Nearly Nine in Ten Respondents [87%] Burn Hours Re-Verifying Context for AI Agents, with 76% Facing Roadblocks Moving from Pilot Programs into Production

NEW YORK and BRUSSELS, Sept. 16, 2026 /PRNewswire/ -- Collibra, the enterprise AI control plane, today announced the findings of a Harris Poll survey of more than 300 U.S. adults ages 21+ who are employed full time as data management, privacy, and/or AI decision-makers. The survey - entitled The 2026 Hallucination Tax Report - found that while nine in ten organizations are actively deploying autonomous AI agents, more than three-quarters (76%) have hit critical roadblocks attempting to move from pilot into full production over the past 12 months.

The research also found that 72% of decision-makers agree that when their organization's AI initiatives fall short, the root cause almost always traces back to an unaligned or poor data foundation. These findings also reflect broader industry trends across enterprise technology, where Gartner research reports that at least 50% of enterprise generative AI projects are abandoned after proof of concept due to poor data quality, escalating costs, and inadequate risk controls.

"The AI conversation across the C-suite has fundamentally shifted from the theoretical to measurable business impact," said Felix Van de Maele, Co-founder and CEO of Collibra. "We have found that every enterprise scaling AI today is paying a hallucination tax — a hidden cost of manual oversight, rework, and risk that grows with every new agent put in production. If human workers have to spend countless hours manually validating every response, the business value of automation ultimately disappears, and companies carry the burden."

Notably, the report highlights that the absence of structured context and runtime governance is forcing organizations back into costly manual supervision, and, in fact, 87% of decision-makers say their teams regularly re-verify that the context their agents have remained accurate and current - creating an unsustainable bottleneck that caps deployment. Additionally, just over half of respondents (51%) report spending significant staff hours manually reviewing and correcting autonomous AI agent outputs before they go live. This operational friction is felt even more acutely among large enterprises: decision-makers at organizations with $100 million or more in revenue are significantly more likely to report manual review drains (64%) and state that the root cause of project failure almost always traces back to poor data foundations (96%).

In response to these operational hurdles, enterprises are fundamentally restructuring their organizational lines to bring machine intelligence and data governance together. More than half of decision-makers (53%) report that the reporting line for their AI function has moved closer to the primary data organization over the past 12 months, rising to 62% among organizations with $100 million or more in revenue. At the same time, an overwhelming 84% of organizations say they have clearly defined executive accountability when autonomous agents produce flawed or harmful outputs.

As global oversight accelerates, enterprise leaders are also taking proactive measures to prepare for shifting regulatory standards. Nine in ten leaders (90%) report that their organizations are actively preparing for evolving AI regulations across federal, state, and international jurisdictions. To ensure long-term compliance and operational transparency, organizations are primarily focusing on establishing clear internal accountability for AI outputs and decisions (58%) and making targeted investments in data lineage and documentation (51%).

"To move from pilots to enterprise-wide production, businesses cannot simply deploy smarter models; they must build the right context and control directly into their workflows," added Van de Maele. "We have focused our latest innovations on solving this exact bottleneck. By providing organizations with the architecture to govern context and enforce automated guardrails at runtime, leaders can finally eliminate the operational friction holding AI back and scale autonomous workflows with certainty."

For more information and to download the complete The 2026 Hallucination Tax Report, please visit collibra.com.

Research Method

This survey was conducted online within the United States by The Harris Poll on behalf of Collibra from August 5 to 11, 2026, among 306 U.S. adults aged 21+ who are employed full-time as data management, privacy, and/or artificial intelligence (AI) decision-makers (director level or higher) at their current company. Data are weighted where necessary based on company size to bring them in line with their actual proportions in the population. The sampling precision of Harris online polls is measured by using a Bayesian credible interval; for this study, the full sample data is accurate to within +/- 6.4 percentage points using a 95% confidence level.

About Collibra

Collibra is the enterprise AI control plane. Built over eighteen years of ontology engineering, it governs context and control across any data, any model and any agent for AI leaders who need certainty at the speed of AI. A 5x Forrester Wave Leader and 2x Gartner Magic Quadrant Leader, Collibra serves more than 700 customers, including 78 of the Fortune 500 and governs more than 2 billion assets.To learn more, visit collibra.com and follow us on LinkedIn, X, Facebook and Instagram.

SOURCE Collibra

Share this article

MADISON, Wis., Sept. 16, 2026 /PRNewswire/ -- Lake Ridge Bank Chief Credit Officer Pete Graven has announced his retirement after nearly 42 years in banking capped off by more than 20 years with Lake Ridge Bank. Graven has spent the last several months mentoring Lake Ridge Bank's newly named Chief Credit Officer Casey McClyman as part of a coordinated succession plan.

Graven Retires on Sept. 18

Graven will leave a legacy of financial excellence and easy-going camaraderie with his departure, having helped ensure sound credit practices in alignment with regulatory guidance for the last two decades. His experience in credit administration, commercial lending, credit risk management, loss mitigation, loan documentation, and loan portfolio performance monitoring has contributed to Lake Ridge Bank's long-term strength, stability and ongoing growth.

"Pete has earned the respect of his fellow bankers, our Board of Directors, our bank clients, and even our institutional examiners and auditors," shares Lake Ridge Bank President Paul Hoffmann. "He is leaving our bank in a better place than he found it, and I am incredibly grateful for his leadership and his friendship over the years."

Graven plans to spend his retirement time traveling, golfing and relaxing at his family cabin.

Casey McClyman named Chief Credit Officer

In July, Casey McClyman returned to Lake Ridge Bank after a 3-year stint at Farmers Savings Bank as Senior Vice President-Chief Credit Officer. Previously, McClyman had spent nearly 20 years at Lake Ridge Bank in a variety of roles, serving the last 10 years as Senior Vice President-Business Relationship Manager on the Business Banking Team. He also has experience in retail services, personal banking, and loan services. McClyman holds his bachelor's degree in Consumer Science and Personal Finance from University of Wisconsin-Madison. He is an active volunteer with Mount Horeb High School, serving as a mentor for its DECA club and as a presenter for the Junior Achievement program. In 2018, he retired from 13 years of service as a Mount Horeb volunteer fire fighter and EMS ambulance driver.

"Casey is someone who really represents our philosophy of community banking," explains Lake Ridge Bank CEO Jim Tubbs. "In addition to his banking expertise, he is ingrained in the local fabric of his community and finding ways to serve others through mentorship and volunteerism. We are very happy to have him step into this role as Chief Credit Officer on our leadership team."

McClyman grew up appreciating the challenges and joys of small business ownership. His father owned and operated a local hardware store.

"I understand what a labor of love small businesses can be for their owners," McClyman admits. "I have a real appreciation for anyone willing to put that kind of effort and passion into their work. These locally owned businesses bring so much depth of character to our neighborhoods. I am looking forward to helping Lake Ridge Bank invest in this type of community growth along with supporting individuals and families building financial security."

To learn more about Lake Ridge Bank, visit lakeridge.bank.

Lake Ridge Bancorp, Inc., through its banking subsidiary, Lake Ridge Bank, offers a full range of business and personal financial services, including business, real estate, agricultural, and consumer lending; crop insurance; wealth management; and financial advisory services. For more information visit: www.lakeridge.bank/lrbancorp. As a community bank, we are dedicated to reinvesting in, and making our communities great places to live, work and raise a family.

Lake Ridge Bank. Go Far. Go Together!

Member FDIC | Equal Housing Lender

SOURCE Lake Ridge Bancorp, Inc.

Share this article

Rising Demand for Early Disease Detection and AI-Enabled Imaging Drives Steady Market Expansion Through 2031

SHERIDAN, Wyo., Sept. 16, 2026 /PRNewswire/ -- The global diagnostic imaging market is projected to grow from USD 26.5 billion in 2026 to USD 33.2 billion by 2031, registering a CAGR of 4.6% during the forecast period (2026–2031), according to a new study by Wissen Research.

Growth is being driven by rising chronic disease prevalence, an expanding geriatric population, and increasing demand for earlier and more precise disease detection. AI-assisted imaging, 3D/4D visualization, and portable imaging devices are improving diagnostic accuracy, streamlining radiology workflows, and extending imaging access across hospitals, outpatient clinics, emergency settings, and rural healthcare facilities.

See the Full Data Behind This Forecast — Get a Free Sample Report:

Where the Technology Is Heading: AI Moves Into the Scanner Itself

The most significant shift in diagnostic imaging is not happening after the scan — it is happening during it. Major manufacturers are embedding deep learning reconstruction (DLR) algorithms directly into image acquisition pipelines, clearing signal-level noise as data is captured rather than cleaning up images afterward.

The clinical impact is measurable. GE HealthCare's Sonic DL sequence now enables complex multi-sequence brain and joint MRI protocols to complete in under 15 minutes, allowing hospitals to increase daily throughput per scanner substantially without new capital equipment. Radiology remains the leading specialty for AI-enabled device clearances, with more than 1,100 cleared by the U.S. FDA to date.

Alongside this, cloud-native PACS and teleradiology platforms are replacing on-premise image archives, enabling remote reads across multi-site networks and reducing reporting turnaround times. Photon-counting CT and hybrid imaging systems are pushing resolution higher while lowering radiation dose, supporting earlier detection in oncology, cardiology, and neurology.

What's Fueling Growth in the Diagnostic Imaging Market

- AI-Enabled Imaging Adoption: AI-based systems are improving diagnostic precision, shortening scan-to-diagnosis time, and raising patient throughput across care settings.

- Cloud PACS and Teleradiology Expansion: Remote reading platforms are accelerating reporting and improving specialist access across distributed hospital networks.

- Photon-Counting CT Commercialization: Ultra-high-definition imaging with reduced radiation exposure is shortening replacement cycles for high-end equipment.

- Portable and Handheld Imaging: Point-of-care ultrasound and mobile systems are expanding diagnostic access in emergency departments, outpatient centers, and rural facilities.

- Safer Contrast Agents: Non-nephrotoxic imaging options are extending diagnostic access to chronic kidney disease patients.

- Certified Refurbished Systems: Lower capital barriers are enabling imaging infrastructure expansion across developing markets.

Need Data Specific to Your Region or Segment? Request a Custom Report

Challenges Facing the Diagnostic Imaging Market

Reimbursement compression is emerging as the sector's most pressing operational constraint. The Centers for Medicare & Medicaid Services introduced an efficiency adjustment in the 2026 Medicare Physician Fee Schedule that permanently reduces work relative value units by 2.5% across roughly 7,700 diagnostic and procedural codes. New combined head and neck CTA codes have produced global payment reductions of up to 30.8%. The result is a growing misalignment between what providers invest in premium scanners and what public payers reimburse — pushing many networks to extend equipment life cycles rather than upgrade.

Beyond reimbursement, high acquisition and maintenance costs for MRI and CT systems remain a barrier for community hospitals and providers in developing markets. A persistent shortage of qualified radiologists is contributing to reporting backlogs, while the shift to cloud-based imaging raises data security and cybersecurity considerations for healthcare providers.

Recent Strategic Developments in the Diagnostic Imaging Market

In May 2026, GE HealthCare introduced next-generation SIGNA MRI technologies and AI-based workflow solutions at ISMRM 2026, including new 3T and helium-free MRI systems, deep learning imaging technologies, and cloud-based research tools.

Also in May 2026, Siemens Healthineers launched an integrated workflow solution for CT-guided percutaneous coronary interventions, combining CT imaging, plaque analysis, procedural planning, and cath lab guidance in a single application.

In March 2026, Samsung Medison consolidated its U.S. medical imaging divisions, NeuroLogica and Boston Imaging, under the Samsung HME America brand, expanding into AI ultrasound, digital radiography, portable CT, and photon-counting detector technologies.

In February 2026, Fujifilm Holdings launched the ARIETTA Deep Insight x ultrasound platform, applying AI and deep learning to improve image quality, with automated workflow tools and real-time virtual sonography.

Key Insights from Diagnostic Imaging Market Analysis

- X-ray systems led the market by modality in 2025, supported by the highest global procedure volumes of any modality, lower installation and shielding requirements, and continued analog-to-digital replacement demand.

- 2D imaging held the largest share by technology type in 2025, driven by faster acquisition and turnaround times, lower infrastructure needs, and the fact that most AI triage algorithms were built around standard 2D radiography and ultrasound workflows.

- North America held the largest regional share in 2025, supported by strong reimbursement, high per-capita imaging volumes, and large health systems with significant purchasing capacity.

- Asia-Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, rising healthcare expenditure, and growing adoption of AI-enabled and portable imaging across urban and underserved areas.

Key Players in the Diagnostic Imaging Market

Leading companies are focused on embedding AI into imaging platforms, expanding cloud and enterprise imaging capabilities, and broadening portable and point-of-care portfolios.

Regional Analysis and Growth Opportunities

North America leads the diagnostic imaging market, underpinned by advanced healthcare infrastructure, high imaging procedure volumes, favorable reimbursement for advanced modalities, and sustained hospital investment in premium imaging technology. An aging population and the formation of large health networks and group purchasing organizations continue to support long-term equipment and service contracts.

Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure expansion, rising healthcare expenditure, and improving access to advanced diagnostics across China, India, Japan, South Korea, and Australia. Government investment in healthcare modernization and the growth of private hospitals and imaging centers are accelerating adoption, while AI-enabled and portable systems are extending diagnostic capability into underserved areas.

Europe, Latin America, and the Middle East & Africa complete the report's regional coverage, with growth shaped by screening program expansion and imaging infrastructure investment.

Wissen Research's healthcare technology analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report:

Market Segmentation Snapshot

The global diagnostic imaging market is segmented across modality, technology, portability, architecture, application, end user, and region:

- By Modality Type:

- X-Ray

- Ultrasound

- Computed Tomography (CT)

- Magnetic Resonance Imaging (MRI)

- Nuclear Imaging (PET/SPECT)

- Mammography

- Fluoroscopy

- By Technology Type:

- 2D Imaging

- 3D/4D Imaging

- AI-Enabled Imaging

- Portable/Point-of-Care Imaging

- Cloud-Based Imaging Informatics

- By Portability Type:

- Fixed Imaging Systems

- Portable/Mobile Imaging Systems

- By Source/Architecture Type:

- Standalone Imaging Systems

- Hybrid Imaging Systems (PET-CT, SPECT-CT, PET-MRI)

- By Application Type:

- Cardiology

- Oncology

- Neurology

- Orthopedics

- Gynecology & Obstetrics

- Pulmonology

- Gastroenterology

- By End User:

- Hospitals

- Diagnostic Imaging Centers

- Ambulatory Surgical Centers

- Specialty Clinics

- Research & Academic Institutes

- By Region:

- North America

- Europe

- Asia-Pacific

- Latin America

- Middle East & Africa

As AI-enabled imaging, photon-counting CT, and cloud-based radiology continue to mature, diagnostic imaging remains a cornerstone of modern healthcare infrastructure. For manufacturers and providers, the path forward lies in balancing continued technology investment against tightening reimbursement, while extending imaging access into outpatient, portable, and underserved care settings.

Get the Complete Diagnostics Imaging Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/diagnostic-imaging-market/

Frequently Asked Questions

Q: What is the size of the diagnostic imaging market? A: The global diagnostic imaging market is estimated at USD 26.5 billion in 2026 and is projected to reach USD 33.2 billion by 2031.

Q: What is the growth rate of the diagnostic imaging market? A: The diagnostic imaging market is projected to grow at a CAGR of 4.6% between 2026 and 2031.

Q: Which modality holds the largest share of the diagnostic imaging market? A: X-ray systems held the largest share by modality in 2025, supported by the highest global procedure volumes and lower installation and infrastructure requirements compared with other modalities.

Q: Which region leads the diagnostic imaging market?

QUÉBEC CITY, Sept. 16, 2026 /PRNewswire/ -- Linearis Labs has been selected to receive funding in two of the 14 pan-Canadian project teams announced today by the Terry Fox Research Institute (TFRI) under its Digital Health Innovation Fund, a program led by TFRI's Digital Health & Discovery Platform (DHDP). The 14 funded projects represent a combined investment of $40.9M and bring together 55 partners across Canada to advance AI-driven health data sharing for precision medicine.

In its announcement, TFRI President and Scientific Director Dr. Jim Woodgett said the initiative reflects "research and enterprise coming together to drive innovation." (Full release: www.dhdp.ca)

Linearis Labs' two funded projects are:

Multi-Omics Data to AI Disease Signature Discovery. In association with MRM Proteomics, Simmunome, the Jewish General Hospital/CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, and Nova Scotia Health. The project applies AI to integrated genomic, proteomic, and metabolomic data to predict which treatments are most likely to work for patients with lung, breast, or colorectal cancers.

AI-Enabled Biomarker Discovery and Therapeutic Monitoring in Neurodegenerative Disease. In collaboration with Nanil Therapeutics, the project uses secure, standardized health data and AI to identify biological signals that can improve how neurodegenerative diseases are studied and monitored.

"Cancer and neurodegenerative diseases are complex, and no single type of data can capture them holistically. By combining genomics, proteomics, and TMIC's 1,780 metabolomics GigaKit™ panel with our AI reasoning layer, we can finally see the whole picture of a disease, not just a fragment, so patients can be diagnosed sooner and treated with what actually works for them," said Alexandre Le Bouthillier, CEO, Linearis Labs.

Both projects will draw on the DHDP's federated learning infrastructure, allowing researchers to analyze data across institutions without moving it, preserving privacy while enabling AI-driven discovery and creating new investment opportunities.

More information on funded projects and participating organizations is available at www.dhdp.ca/projects

About Linearis

Linearis, with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies. To learn more about Linearis, visit www.linearis.com

SOURCE Linearis

Share this article

GREENWICH, Conn., Sept. 16, 2026 /PRNewswire/ -- NicholsMD of Greenwich is introducing a new approach to the traditional dermatology experience with the opening of The Brewtique, an in-house coffee shop located within its new flagship at 32 Field Point Road. Offering complimentary premium coffee and tea, The Brewtique extends the patient experience beyond clinical care, bringing the warmth and familiarity of a café into the time surrounding an appointment.

Understanding that patients increasingly value experiences that fit seamlessly into their lives, The Brewtique was designed to bring an added layer of ease to the dermatology visit. Rather than treating hospitality as an added amenity, it becomes part of the patient experience itself, turning time spent waiting for an appointment into an opportunity to settle in, enjoy a thoughtfully prepared beverage, and have a moment to themselves before entering the treatment room.

Patients can enjoy complimentary freshly roasted Partners Coffee and premium Harney & Sons teas, handcrafted by a dedicated barista and served hot, iced, or shaken. A Brooklyn-based specialty coffee company, Partners sources its coffee through long-standing relationships with producers around the world and roasts fresh daily at its Brooklyn roastery, prioritizing quality, seasonality, and sustainability over a mass-produced approach. The same attention to quality and thoughtful sourcing that defines Partners makes it a natural fit for The Brewtique, where even a patient's cup of coffee is intentionally considered.

A full-time, dedicated barista will be offering a rotating menu of seasonal specialty drinks gives patients something new to discover throughout the year. For returning patients, favorite beverage preferences can also be remembered for future visits, making a regular order another familiar, personalized part of the experience.

"A cornerstone of Partners Coffee has always been the partnerships we build along the way. That means long-term relationships with the farmers and producers who grow our coffee, and the same commitment to the wholesale customers who serve it. We love working with folks who share that same attention to detail we bring to our own cafes, and this partnership with NicholsMD gives us a chance to put thoughtfully sourced coffee in front of guests who appreciate the difference," said Raina Roberts, Business Development Director at Partners Coffee.

"We understand that our patients live busy lives, and we want the time they spend with us to complement, rather than interrupt, their day," said Dr. Kim Nichols, Board-Certified Dermatologist and Founder of NicholsMD. "Coming to the dermatologist can sometimes feel clinical or intimidating, and I've always wanted the opposite for my patients. I want them to walk through our doors and immediately feel comfortable, welcomed, and genuinely cared for. The Brewtique is a natural extension of that."

The Brewtique is one of several patient-focused additions introduced with NicholsMD's move to its expanded Greenwich flagship. Housed within a beautifully restored historic building, the new space also features advanced treatment suites, personalized consultation spaces, state-of-the-art technology, and The Hair Lab™, a dedicated destination for dermatologist-led hair restoration, scalp health, and laser hair removal.

Together, these additions reflect an evolution of the traditional dermatology visit, pairing medical expertise and advanced technology with thoughtful details that make the time surrounding an appointment feel just as considered as the care itself.

NicholsMD of Greenwich is located at 32 Field Point Road in Greenwich, Connecticut, and is welcoming new patients for comprehensive medical and cosmetic dermatology, skin cancer screenings, injectables, laser treatments, hair restoration, body shaping, regenerative aesthetic treatments, and personalized skincare.

ABOUT NICHOLSMD OF GREENWICH

Founded in 2013, NicholsMD of Greenwich is the first and only boutique dermatology practice in Greenwich, Connecticut. Led by board-certified dermatologist Dr. Kim Nichols, the practice has become a premier destination for medical, cosmetic, and regenerative dermatology, offering concierge-level care across three Fairfield County locations. NicholsMD specializes in advanced injectables with natural-looking results, regenerative treatments, and precision anti-aging rooted in science and artistry.

SOURCE NicholsMD of Greenwich

Share this article

UNIONDALE, N.Y., Sept. 16, 2026 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its Board of Directors declared cash dividends on its Preferred Stock.

The Company will pay a cash dividend on its 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock ("Series C Preferred Stock") in the amount of $0.610625 per share, which reflects a rate of 9.77%, equal to three-month Term SOFR on the dividend determination date plus a spread of 5.927% per annum. The dividend will be payable on October 30, 2026, to holders of record on October 1, 2026.

The Company will also pay a cash dividend on its 7.875% Series D Cumulative Redeemable Preferred Stock in the amount of $0.4921875 per share. The dividend will be payable on October 30, 2026, to holders of record on October 1, 2026.

About ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp. is a public commercial mortgage REIT that is primarily focused on originating, holding and managing commercial real estate mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The Company is dedicated to nationwide middle market lending with a focus on multifamily, student housing, hospitality, industrial and office properties in top U.S. markets. For more information, please visit the Company's website at www.acresreit.com or contact investor relations at [email protected].

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as "may," "trend," "will," "continue," "expect," "intend," "anticipate," "estimate," "believe," "look forward" or other similar words or terms. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. Factors that can affect future results are discussed in the documents filed by the Company from time to time with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any forward-looking statement to reflect new or changing information or events after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law.

SOURCE ACRES Commercial Realty Corp.

Share this article

TRIN dividend has remained consistent for seven years

PHOENIX, Sept. 16, 2026 /PRNewswire/ -- Trinity Capital Inc. (NYSE: TRIN) ("the Company"), a leading international alternative asset manager, today announced that its Board of Directors declared a monthly regular dividend of $0.17 per share for each of October, November, and December 2026.

This is an equivalent monthly distribution as the first nine months of 2026. Trinity Capital shareholders have now received a consistent or increased dividend for seven consecutive years.

Summary of the upcoming dividends for the Fourth Quarter 2026:

The Company's objective is to distribute regular dividends in an amount that approximates 90% to 100% of its taxable quarterly income or potential annual income for a particular year in order to qualify for tax treatment as a regulated investment company under the Internal Revenue Code of 1986. In addition, during any particular year, the Company may pay additional supplemental dividends, so that the Company distributes approximately all its annual taxable income in the year it was earned, or it may spill over the excess taxable income into the coming year for future dividend payments.

Dividends are paid from taxable earnings and may include a return of capital and/or capital gains. The specific tax characteristics of the dividends will be reported to stockholders on Form 1099-DIV after the end of the calendar year and in the Company's periodic reports filed with the Securities and Exchange Commission.

About Trinity Capital Inc.

Trinity Capital Inc. (NYSE: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Tech Lending, Equipment Finance, Healthcare & Life Sciences, Sponsor Finance, and Asset Based Lending. Headquartered in Phoenix, Arizona, Trinity Capital's dedicated team is strategically located across the United States and Europe. For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via LinkedIn.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission ("SEC"). The Company undertakes no duty to update any forward-looking statement made herein, unless required by law. All forward-looking statements speak only as of the date of this press release. More information on risks and other potential factors that could affect the Company's financial results, including important factors that could cause actual results to differ materially from plans, estimates or expectations, is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed annual report on Form 10-K and subsequent SEC filings.

SOURCE Trinity Capital Inc.

Share this article

RESTON, Va., Sept. 16, 2026 /PRNewswire/ -- CACI International Inc (NYSE: CACI) announced today that it has received a one-year plus four option periods award to support U.S. Central Command (USCENTCOM) and its mission partners across a demanding and rapidly changing mission environment. The award has a ceiling of $1.5 billion. CACI expects to book $1.2 billion of the total awarded value.

"CENTCOM operates in one of the world's most challenging regions, where intelligence must move quickly from insight to action," said John Mengucci, CACI President and Chief Executive Officer. "CACI brings the knowledge and advanced capabilities to help U.S. and partner forces act with speed, clarity, and confidence in support of our national security interests."

Through Apollo, CACI will help USCENTCOM make faster decisions and coordinate more effectively across commands and partners. The company's capabilities will enhance planning, analysis, information integration, and mission execution across the command's area of responsibility. CACI will help commanders turn information into actionable insight and operate with greater confidence in contested or denied territories, allowing warfighters to out-compete adversaries in the information environment.

The award builds on CACI's experience with irregular warfare missions across geographic and functional combatant commands. Under this award, CACI will apply that experience to strengthen USCENTCOM's planning, coordination, and operational readiness for its most critical mission requirements.

About CACI

CACI International Inc (NYSE: CACI) is a technology-first national security company that expands the limits of national security through innovation, discipline, and operational excellence. We deliver advanced technologies that help our customers move faster, operate more efficiently, and anticipate and defeat evolving threats. Our 27,000 talented employees and strong culture drive our success and have earned CACI recognition as a Fortune World's Most Admired Company. CACI is a member of the Fortune 500™, the Russell 1000 Index, and the S&P MidCap 400 Index. For more information, visit caci.com.

SOURCE CACI International Inc

Share this article

DOWNERS GROVE, Ill., Sept. 16, 2026 /PRNewswire/ -- Dover (NYSE: DOV) announced today that it will release third quarter 2026 earnings at approximately 6:00 a.m. Central time (7:00 a.m. Eastern time) on Thursday, October 22, 2026. Later that morning, Dover will host a conference call at 8:30 a.m. Central time (9:30 a.m. Eastern time) to discuss these results.

To participate in the conference call, please dial 1 (800) 225-9448 (domestic) or 1 (203) 518-9708 (international), conference ID DOVQ326. Due to the expected number of callers, please dial in at least 15 minutes before the conference is to begin and ask to be connected to the Dover teleconference.

A link to the live audio webcast will also be available on the company website at dovercorporation.com. An audio replay of the conference call will be available from 12:00 p.m. Central time, October 22, until 10:59 p.m. Central time, November 12, by dialing 1 (800) 753-8591 (domestic) or 1 (402) 220-0686 (international). Additionally, a replay link of the webcast will be archived on Dover's website for 90 days.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 70 years, our team of approximately 24,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com.

SOURCE Dover

Share this article

Nelnet Board of Directors Appoints Two New Members

LINCOLN, Neb., Sept. 16, 2026 /PRNewswire/ -- Nelnet, Inc. (NYSE: NNI) today announced the appointment of Angie Klein and Ed Pallesen to its board of directors, expanding the board to 10 members. Klein, who recently joined Apple, brings nearly 25 years of consumer marketing and growth leadership from her extensive tenure at Verizon; Pallesen brings over 25 years in financial services and infrastructure investing, including roles at H.I.G. Capital and Goldman Sachs.

"We are pleased to welcome Angie and Ed to the Nelnet board," said Mike Dunlap, executive chairman of Nelnet. "Both have demonstrated outstanding leadership throughout their careers and bring distinct experiences that will broaden and strengthen the perspectives represented in our boardroom. Their insights will be valuable as we continue building on Nelnet's strong foundation and pursuing opportunities that support our core values and the long-term success of the company."

Klein currently serves as head of U.S. consumer channels for Apple, leading the company's sales and distribution partnerships with retailers, including Best Buy, Amazon, Walmart, Target and Costco. She previously spent nearly 25 years at Verizon, including as chief content officer and senior vice president of growth marketing and as the inaugural president of Verizon Value, where she led a multi-brand prepaid portfolio serving millions of customers. Klein holds marketing and advertising degrees from the University of Nebraska–Lincoln and is a David Rockefeller Fellow and a fellow of The Marketing Academy. Klein will serve on the Nominating and Corporate Governance, People Development and Compensation, and Compliance committees.

Pallesen has more than 25 years of experience in financial services, including roles at Goldman Sachs Group, Inc. Since 2019, he has served as managing director and global head of infrastructure at H.I.G. Capital, a global middle-market private alternatives investment firm. His areas of investment include, among other areas, digital infrastructure and renewable energy. Pallesen earned his undergraduate degree from Harvard College, an M.Phil. and D.Phil. from Oxford University, where he was a Rhodes Scholar, and a law degree from Harvard Law School. He is a trustee of the University of Nebraska Foundation. Pallesen will serve on the Nominating and Corporate Governance and Risk and Finance committees.

About Nelnet

Nelnet is a diversified company with primary businesses in consumer lending, loan servicing, payments and technology — all with a strong focus on the education space. Headquartered in Lincoln, Neb., Nelnet has more than 5,700 associates. Learn more at Nelnet.com.

SOURCE Nelnet, Inc.

Share this article